These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2079074)

  • 41. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma growth hormone responses to growth hormone-releasing hormone in children of short stature.
    Tsai WY; Chen SH; Lee JS
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):801-5. PubMed ID: 2512368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
    Alba M; Schally AV; Salvatori R
    Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors influencing the growth hormone response to growth hormone-releasing hormone in children with idiopathic growth hormone deficiency.
    Groisne C; Trivin C; Souberbielle JC; Brauner R
    Horm Res; 2002; 58(2):94-8. PubMed ID: 12207169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroendocrine study of a male infant with septo-optic dysplasia.
    Sirota L; Dickerman Z; Laron Z; Weitz R; Dulitzky F
    Isr J Med Sci; 1985 Sep; 21(9):745-9. PubMed ID: 3877029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optic nerve size evaluated by magnetic resonance imaging in children with optic nerve hypoplasia, multiple pituitary hormone deficiency, isolated growth hormone deficiency, and idiopathic short stature.
    Birkebaek NH; Patel L; Wright NB; Grigg JR; Sinha S; Hall CM; Price DA; Lloyd IC; Clayton PE
    J Pediatr; 2004 Oct; 145(4):536-41. PubMed ID: 15480381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of hypothalamic dysfunction in growth hormone (GH)-deficient patients using single versus multiple doses of GH-releasing hormone (GHRH-44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH-deficient patients.
    Schriock EA; Hulse JA; Harris DA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1177-82. PubMed ID: 3119651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Growth hormone-releasing hormone. The physiopathologic aspects and its diagnostic-therapeutic use].
    De Marinis L; Mancini A; La Brocca A; D'Amico C; Sambo P; Tofani A; Barbarino A
    Minerva Med; 1989 Apr; 80(4):325-34. PubMed ID: 2566960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Optic nerve hypoplasia and growth hormone deficiency: de Morsier's syndrome].
    Mutz I; Millner M; Borkenstein M
    Wien Klin Wochenschr; 1984 May; 96(11):432-5. PubMed ID: 6475068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Septo-optic dysplasia with antidiuretic hormone deficiency and central adrenocortical insufficiency. Three cases report in infants (author's transl)].
    Benoit Gonin JJ; David M; Feit JP; Bourgeois J; Chopard A; Kopp N; Jeune M
    Nouv Presse Med; 1978 Oct; 7(37):3327-31. PubMed ID: 733502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Septo-optic dysplasia/optic nerve hypoplasia: data from the National Cooperative Growth Study (NCGS).
    Parker KL; Hunold JJ; Blethen SL
    J Pediatr Endocrinol Metab; 2002 May; 15 Suppl 2():697-700. PubMed ID: 12092683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spontaneous recovery from post-traumatic hypopituitarism.
    Iglesias P; Gómez-Pan A; Diez JJ
    J Endocrinol Invest; 1996 May; 19(5):320-3. PubMed ID: 8796342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma GH response to the sequential 3 day administrations of GHRH followed by arginine infusion in patients with idiopathic GH deficiency and normal short children.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Tazawa S; Abe K
    Tohoku J Exp Med; 1993 Feb; 169(2):91-101. PubMed ID: 8236247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism.
    Tanriverdi F; Unluhizarci K; Coksevim B; Selcuklu A; Casanueva FF; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):360-6. PubMed ID: 17302869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The endocrine spectrum of septo-optic dysplasia.
    Izenberg N; Rosenblum M; Parks JS
    Clin Pediatr (Phila); 1984 Nov; 23(11):632-6. PubMed ID: 6488662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.